Philosophy Clear Days Ahead Acne Treatment

Sulfur


Philosophy, Inc.
Human Otc Drug
NDC 50184-1067
Philosophy Clear Days Ahead Acne Treatment also known as Sulfur is a human otc drug labeled by 'Philosophy, Inc.'. National Drug Code (NDC) number for Philosophy Clear Days Ahead Acne Treatment is 50184-1067. This drug is available in dosage form of Lotion. The names of the active, medicinal ingredients in Philosophy Clear Days Ahead Acne Treatment drug includes Sulfur - 10 g/100mL . The currest status of Philosophy Clear Days Ahead Acne Treatment drug is Active.

Drug Information:

Drug NDC: 50184-1067
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Philosophy Clear Days Ahead Acne Treatment
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Sulfur
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Philosophy, Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Lotion
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:SULFUR - 10 g/100mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 01 Aug, 2020
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 15 Jan, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part333D
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2024
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Philosophy, Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:240725
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UNII:70FD1KFU70
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
50184-1067-128 mL in 1 BOTTLE (50184-1067-1)01 Aug, 2020N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose acne treatment

Product Elements:

Philosophy clear days ahead acne treatment sulfur water titanium dioxide chromium hydroxide green ferrosoferric oxide alcohol triethoxycaprylylsilane pantolactone, (r)- salicylic acid panthenol aluminum hydroxide zinc oxide disodium stearoyl glutamate ferric oxide red hamamelis virginiana top water sulfur sulfur

Indications and Usage:

Use for the treatment of acne.

Warnings:

Warnings for external use only. do not use broken skin large areas of the skin when using this product skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. if irritation occurs, only use one topical acne medication at a time. apply only to areas with acne. avoid contact with eyes. if contact occurs, flush with plenty of water. if undue skin irritation develops or increases, discontiue use. if irritation persists, consult a physician. keep out of reach of children if swallowed, get medical help or contact poison control center right away.

Do Not Use:

Warnings for external use only. do not use broken skin large areas of the skin when using this product skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. if irritation occurs, only use one topical acne medication at a time. apply only to areas with acne. avoid contact with eyes. if contact occurs, flush with plenty of water. if undue skin irritation develops or increases, discontiue use. if irritation persists, consult a physician. keep out of reach of children if swallowed, get medical help or contact poison control center right away.

When Using:

When using this product skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. if irritation occurs, only use one topical acne medication at a time. apply only to areas with acne. avoid contact with eyes. if contact occurs, flush with plenty of water. if undue skin irritation develops or increases, discontiue use. if irritation persists, consult a physician.

Dosage and Administration:

Directions clean the skin thoroughly before applying this product. shake well and dip a cotton swab into the product. dab directly onto acne and let dry. cover the entire affected area with a thin layer one to three times daily. because excessive drying of the skin may occur, start with one application daily, then gradually increase to two times daily if needed or as directed by a doctor. if bothersome dryness or peeling occurs, reduce application to once a day or every other day.

Package Label Principal Display Panel:

Clear days ahead philosophy: clarity is a clear state of being. acne treatment drying lotion with 10% sulfur philosophy 28 ml/0.9 fl. oz. e primary carton

Further Questions:

Questions or comments? call toll-free 1-800-568-3151 from 9 a.m. – 8 p.m. et (monday –friday)


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.